Prevention of abortion by ciclosporin treatment of fulminant ulcerative colitis during pregnancy

Por Angelberger, S, Reinisch, W, Dejaco, C
Publicado em 2006

Poor diagnostic value of colonic CD44v6 expression and serum concentrations of its soluble form in the differentiation of ulcerative colitis from Crohn's disease

Por Reinisch, W, Heider, K, Oberhuber, G, Dejaco, C, Mullner, M, Adolf, G, Gasche, C
Publicado em 1998

Donor dependent, interferon-γ induced HLA-DR expression on human neutrophils in vivo

Por REINISCH, W, LICHTENBERGER, C, STEGER, G, TILLINGER, W, SCHEINER, O, GANGL, A, MAURER, D, WILLHEIM, M
Publicado em 2003

Anti‐outer membrane of porin C and anti‐I2 antibodies in indeterminate colitis

Por Joossens, S, Colombel, J‐F, Landers, C, Poulain, D, Geboes, K, Bossuyt, X, Targan, S, Rutgeerts, P, Reinisch, W
Publicado em 2006

Allogeneic expanded adipose‐derived stem cells in the treatment of rectovaginal fistulas in Crohn’s disease

Por Nikolic, M., Stift, A., Reinisch, W., Vogelsang, H., Matic, A., Müller, C., von Strauss und Torney, M., Riss, S.
Publicado no Colorectal Dis (2020)

Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?

Por Miehsler, W, Reinisch, W, Valic, E, Osterode, W, Tillinger, W, Feichtenschlager, T, Grisar, J, Machold, K, Scholz, S, Vogelsang, H, Novacek, G
Publicado em 2004

Population pharmacokinetics‐pharmacodynamics of vedolizumab in patients with ulcerative colitis and Crohn's disease

Por Rosario, M., Dirks, N. L., Gastonguay, M. R., Fasanmade, A. A., Wyant, T., Parikh, A., Sandborn, W. J., Feagan, B. G., Reinisch, W., Fox, I.
Publicado no Aliment Pharmacol Ther (2015)

Randomised clinical study: discrepancies between patient‐reported outcomes and endoscopic appearance in moderate to severe ulcerative colitis

Por Jharap, B., Sandborn, W. J., Reinisch, W., D'Haens, G., Robinson, A. M., Wang, W., Huang, B., Lazar, A., Thakkar, R. B., Colombel, J.‐F.
Publicado no Aliment Pharmacol Ther (2015)

Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine

Por Vernier‐Massouille, G, Cosnes, J, Lemann, M, Marteau, P, Reinisch, W, Laharie, D, Cadiot, G, Bouhnik, Y, De Vos, M, Boureille, A, Duclos, B, Seksik, P, Mary, J‐Y
Publicado em 2007

Randomised clinical trial: a placebo‐controlled study of intravenous golimumab induction therapy for ulcerative colitis

Por Rutgeerts, P., Feagan, B. G., Marano, C. W., Padgett, L., Strauss, R., Johanns, J., Adedokun, O. J., Guzzo, C., Zhang, H., Colombel, J.‐F., Reinisch, W., Gibson, P. R., Sandborn, W. J.
Publicado no Aliment Pharmacol Ther (2015)

A randomised placebo controlled trial of pegylated interferon α in active ulcerative colitis

Por Tilg, H, Vogelsang, H, Ludwiczek, O, Lochs, H, Kaser, A, Colombel, J-F, Ulmer, H, Rutgeerts, P, Krüger, S, Cortot, A, D’Haens, G, Harrer, M, Gasche, C, Wrba, F, Kuhn, I, Reinisch, W
Publicado em 2003

European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis

Por Stange, E F, Travis, S P L, Vermeire, S, Beglinger, C, Kupcinskas, L, Geboes, K, Barakauskiene, A, Villanacci, V, Von Herbay, A, Warren, B F, Gasche, C, Tilg, H, Schreiber, Stefan W, Schölmerich, J, Reinisch, W
Publicado em 2006

A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti‐interferon γ antibody, in patients w...

Por Reinisch, W, Hommes, D W, Van Assche, G, Colombel, J‐F, Gendre, J‐P, Oldenburg, B, Teml, A, Geboes, K, Ding, H, Zhang, L, Tang, M, Cheng, M, van Deventer, S J H, Rutgeerts, P, Pearce, T
Publicado em 2006

A68 COST EFFECTIVENESS OF TIGHT CONTROL FOR CROHN’S DISEASE WITH ADALIMUMAB-BASED TREATMENT: ECONOMIC EVALUATION OF CALM TRIAL FROM CANADIAN PERSPECTIVE

Por Panaccione, R, Colombel, J, Bossuyt, P, Baert, F, Vanasek, T, Danalioglu, A, Novacek, G, Armuzzi, A, Reinisch, W, Johnson, S, Buessing, M, Neimark, E, Petersson, J, Robinson, A M, Thakkar, R B, Lee, W, Skup, M, D’Haens, G
Publicado no J Can Assoc Gastroenterol (2019)

The management of iron deficiency in inflammatory bowel disease – an online tool developed by the RAND/UCLA appropriateness method

Por Reinisch, W, Chowers, Y, Danese, S, Dignass, A, Gomollón, F, Haagen Nielsen, O, Lakatos, P L, Lees, C W, Lindgren, S, Lukas, M, Mantzaris, G J, Michetti, P, Moum, B, Peyrin-Biroulet, L, Toruner, M, Woude, J, Weiss, G, Stoevelaar, H
Publicado em 2013

Guidelines on the use of extracorporeal photopheresis

Por Knobler, R, Berlin, G, Calzavara-Pinton, P, Greinix, H, Jaksch, P, Laroche, L, Ludvigsson, J, Quaglino, P, Reinisch, W, Scarisbrick, J, Schwarz, T, Wolf, P, Arenberger, P, Assaf, C, Bagot, M, Barr, M, Bohbot, A, Bruckner-Tuderman, L, Dreno, B, Enk, A, French, L, Gniadecki, R, Gollnick, H, Hertl, M, Jantschitsch, C, Jung, A, Just, U, Klemke, C-D, Lippert, U, Luger, T, Papadavid, E, Pehamberger, H, Ranki, A, Stadler, R, Sterry, W, Wolf, IH, Worm, M, Zic, J, Zouboulis, CC, Hillen, U
Publicado no J Eur Acad Dermatol Venereol (2014)